What BOC Sciences does

BOC Sciences is a privately held chemical supplier and contract development and manufacturing organization (CDMO) headquartered in Shirley, New York, with a European regional office in Frankfurt am Main, Germany. Founded in 2005, the company serves life sciences, biotechnology, and pharmaceutical clients across more than 60 countries, claiming over 6,000 global partners and more than a decade of continuous operation. Its customer base spans pharmaceutical companies, biotech firms, academic and research institutions, and vaccine and immunotherapy developers, served through a combination of self-service e-commerce, direct sales, and quote-based custom engagement.

The company's core offering is an integrated portfolio that combines catalog sales of research chemicals with custom synthesis and cGMP contract manufacturing. The catalog spans small-molecule inhibitors, PROTAC products, antibody-drug conjugates (ADCs), vaccine adjuvants, more than 20,000 pharmaceutical impurity reference standards, metabolites, GMP products, APIs (including US DMF- and EU DMF-approved anthracyclines), excipients, nucleosides, nucleotides, amino acids, chiral compounds, natural compounds, and specialty life science reagents. On the services side, BOC Sciences operates custom synthesis, microbial fermentation, analytical, bioconjugation, drug delivery (liposomes, nanoparticles, mRNA/siRNA delivery), and CDMO capabilities at scales from 1kg to 1,000kg. It has also built proprietary technology platforms branded as BOC Nano™, APOC™, GlycoAOCT™, and LipCeDS™, and recently launched the Glycan Portal (October 2025) to support glycoscience research.

BOC Sciences generates revenue through multiple streams: catalog product sales priced by unit and purity, quote-based custom synthesis projects, multi-year CDMO contracts for cGMP manufacturing, professional services for AI-assisted drug discovery, and emerging technology licensing through its APOC/GlycoAOCT/LipCeDS programs. Pricing is primarily quote-based for custom and bulk orders, with reference catalog unit prices ranging from approximately $197 to $1,999 depending on product, purity, and quantity. Demand generation is led by an SEO-optimized product catalog, technical blog content, webinars, social media presence, and conference participation, while order capture is handled through direct phone/email channels and an online inquiry basket on bocsci.com.

Name

BOC Sciences

Legal name

BOC Sciences

Website

https://bocsci.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BOC Sciences is a privately held chemical supplier and CDMO serving pharmaceutical, biotechnology, academic, and life sciences clients worldwide with research chemicals, custom synthesis, cGMP manufacturing, and emerging drug discovery and drug delivery platforms.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing & Research Chemicals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), DMPK / ADME & Bioanalysis (HLAGAFAC), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• Research chemicals supply
• Pharmaceutical CDMO services
• Custom chemical synthesis
• PROTAC drug discovery
• Antibody-drug conjugates

Headquarters

HQ city

Shirley

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Chemicals & Products Sales: BOC Sciences generates revenue through the sale of research chemicals including small-molecule inhibitors, pharmaceutical impurities, metabolites, intermediates, APIs, GMP products, natural compounds, amino acids, nucleotides, and life science products. Products are sold in research-grade to GMP-compliant specifications ranging from milligrams to commercial kilogram quantities.
2. Custom Synthesis Services: Revenue from bespoke chemical synthesis services including custom synthesis of pharmaceutical intermediates, metabolites, isotope-labeled compounds, nucleoside/nucleotide intermediates, and heterocyclic compounds. Services include chiral synthesis, resolution, and process optimization.
3. CDMO Services: Contract Development and Manufacturing Organization services including cGMP manufacturing (small scale 1kg to commercial quantities 1000kg), CMC, formulation services, process development, and quality control for pharmaceutical clients.
4. AI Drug Discovery Services: AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.
5. Drug Delivery Solutions: Specialized drug delivery platform services including cell-based delivery, hydrogel delivery, liposome delivery, microspheres, nanoparticle delivery, peptide-based delivery, polymer-based delivery, exosome-based delivery, mRNA delivery, siRNA delivery, and carbohydrate-based delivery systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

BOC Sciences manufactures and supplies a broad catalog of research chemicals, pharmaceutical intermediates, impurities, metabolites, amino acids, nucleotides, oligonucleotides, enzymes, excipients, APIs, and GMP-compliant products for pharmaceutical, biotechnology, and academic research customers. It also delivers contract development and manufacturing organization (CDMO) services, custom synthesis, bioconjugation, analytical services, drug delivery solutions, and AI-powered drug discovery across advanced therapeutic modalities including PROTAC, ADC, RNA, and nanotechnology.

Product overview

BOC Sciences is a diversified chemical and pharmaceutical company offering an integrated portfolio of research chemicals, APIs, and contract services. The core product lines include small-molecule inhibitors, PROTAC products, vaccine adjuvants, pharmaceutical impurity standards (20,000+ products), metabolites, antibody-drug conjugates (ADCs), pharmaceutical excipients, APIs, GMP products, chemical intermediates, amino acids, chiral compounds, natural compounds, nucleotides, oligonucleotides, enzymes, and phospholipids. The service portfolio encompasses AI drug discovery, microbial fermentation, drug delivery solutions (including liposomes, nanoparticles, mRNA/siRNA delivery), custom synthesis, bioconjugation, analytical services, and CDMO services. The company operates under GMP-compliant and ISO-certified standards, serving clients in more than 60 countries. The Glycan Portal (launched October 2025) represents their latest product initiative in glycoscience.

Differentiator

Problem solved

Functional benefit

Brands

• BOC NanoTM Platform: Nanotechnology platform for drug delivery and nanoparticle development services
• Glycan Portal
• APOC™ (Antibody Peptide Oligonucleotide Conjugation)
• GlycoAOCT™ (Glycosylated Antibody-Oligonucleotide Conjugates Technology)
• LipCeDS™ (Lipid-based Chem Enhanced Delivery System)

Products and services

• Small-Molecule Inhibitors High-purity small-molecule inhibitors, agonists and modulators synthesized to research-grade or GMP-compliant specifications for precision-targeted drug discovery and screening, available from milligrams to kilograms.
• PseudoUridine Bulk PseudoUridine and derivatives for global R&D and manufacturing, optimized for mRNA vaccine development and nucleic acid research.
• Nucleosides & Nucleotides Biograde nucleosides and nucleotides in research and production-scale quantities for mRNA therapeutics and oligonucleotide production.
• PROTAC Products PROTAC molecular discovery products including E3 ligase ligands, linkers, and target protein ligands for targeted protein degradation drug discovery.
• Vaccine Adjuvants Comprehensive vaccine adjuvant products including aluminum salts, cytokines, saponins, CpG oligonucleotides, liposome adjuvants, oil emulsion adjuvants, and polymer nanoparticles for human and animal vaccine development.
• Pharmaceutical Impurity Standards Over 20,000 pharmaceutical impurity products including API-related impurities, degradation products, process-related impurities, metabolites, nitrosamine impurities, and chiral impurities with COA/HPLC/MS/NMR documentation.
• Metabolites High-purity primary and secondary metabolites from microbial sources (Actinoplanes, Aspergillus, Bacillus, Streptomyces, and others) and analogue sets for various antibiotic classes.
• Antibody-Drug Conjugate (ADC) Products & Services Complete suite of ADC offerings including antibody modification and conjugation technologies, ADC payload and payload-linker synthesis, ADC conjugation, characterization, and manufacturing.
• Pharmaceutical Excipients Pharmaceutical-grade excipients including fillers, diluents, binders, suspension agents, coatings, flavoring agents, disintegrants, colorants, lubricants, preservatives, sweeteners, and emulsifiers.
• Active Pharmaceutical Ingredients (APIs) Synthetic, biological, plant-derived, and radiopharmaceutical APIs including anthracyclines such as Daunorubicin HCl, Doxorubicin HCl, Epirubicin HCl (with US DMF and EU DMF), and Valrubicin.
• GMP Products Good Manufacturing Practice compliant products including GMP Cholesterol, GMP Guanosine-5'-triphosphate, GMP Imiquimod, GMP Paclitaxel, GMP Docetaxel, and other pharmaceutical-grade compounds.
• Chemical Intermediates High-quality chemical intermediates including pharmaceutical, pesticide, and polymer intermediates supporting research, development, and industrial production.
• Amino Acids Comprehensive amino acid catalog including D-, L-, DL-, β-, γ-amino acids, Fmoc-, BOC-, CBZ-amino acids, cyclic, fluorinated, and unnatural amino acids.
• Chiral Compounds Chiral compounds supporting stereochemical control in pharmaceutical research and development.
• Natural Compounds Natural compounds extracted from microorganisms or plants for analytical testing and various industry applications.
• Stable Isotope Labelled Compounds Isotope-labeled compounds for metabolic studies and analytical chemistry research applications.
• Flavor & Fragrance Compounds Flavor and fragrance compounds for food, beverage, and cosmetic industry applications.
• Superparamagnetic Iron Oxide Nano/Micro Particles Nano and micro superparamagnetic iron oxide particles prepared for research and industrial applications.
• Nanoemulsions Nanoscale emulsions (20–200 nm droplet size) stabilized by surfactants for pharmaceutical, food, cosmetics, and industrial applications.
• Oligonucleotides Synthetically produced short strands of nucleotides (2–50 nucleotides) for research, diagnostics, and therapeutic applications.
• Enzymes High-purity enzymes for research, diagnostics, and industrial applications including glycobiology, molecular biology, clinical chemistry, and metabolic analysis.
• Stem Cell Molecules Small molecules with high selectivity and stable physicochemical properties for stem cell biology including induced differentiation, reprogramming, and transdifferentiation.
• Fluorescent Probes Single fluorophores and fluorophores covalently bound to biomolecules, including cell and organelle stains, DNA stains, fluorescent enzyme substrates, ion indicators, and pH indicators.
• Chemiluminescent Substrates Chemiluminescent agents that transfer energy in chemical reactions to release light, used as detection tools for proteins and nucleic acids.
• Phospholipids Amphiphilic lipids with glycerol or sphingosine backbones used as emulsifiers and dispersants in cosmetics, food, nutrition, and pharmaceutical formulations.
• Microbial Fermentation Services Contract manufacturing services for custom microbial solutions supporting biopharma, agriculture, and synthetic biology applications.
• AI Drug Discovery Services AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.
• Drug Delivery Solutions Drug delivery services spanning cell-based, hydrogel, liposome, microsphere, nanoparticle, peptide-based, polymer-based, exosome-based, carbohydrate-based, mRNA, RNA, and siRNA delivery modalities.
• RNA Technology Services RNA technology services including nucleoside synthesis, nucleotide synthesis, and custom RNA synthesis for therapeutics development.
• Custom Synthesis Services Custom synthesis services including glycogen, glycans, chiral resolution, nucleoside, nucleotide, and carbohydrate synthesis.
• Bioconjugation Services Bioconjugation services including isotope labeling and fluorescent labeling of proteins.
• CDMO Services Contract Development and Manufacturing Organization services including cGMP capacity (1 kg to 1,000 kg), ingredient combination, CMC, formulation services, process development, and quality control.
• Analytical Services Analytical services including XDC analysis, crystallization services, lab testing, animal testing for inhibitors, contract purification, and impurity identification and analysis.
• Glycan Portal Online portal launched in October 2025 to support glycoscience research, development, and commercialization, providing reagents and services for therapeutics, diagnostics, and biomarker discovery.

Quantifiable outcome

• Serving clients in more than 60 countries worldwide
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves3 records

Expansion highlights6 records

Direct peers

• WuXi AppTec: Global CRO/CDMO offering custom synthesis, small-molecule CMC, APIs, and impurity reference standards with extensive GMP capacity. WuXi AppTec is the closest direct competitor to BOC Sciences' combined research-chemical and CDMO model, though at significantly larger scale.
• TCI Chemicals: Tokyo Chemical Industry is a direct competitor in research chemicals, organic intermediates, and custom synthesis with a similarly global distribution footprint. Comparable product catalog depth and target customers in pharma, biotech, and academic research.
• Combi-Blocks: Direct competitor focused on building blocks, custom synthesis, and reference standards for pharma and biotech research. Comparable business model combining catalog sales with custom synthesis services targeting drug discovery customers.
• Bide Pharmatech: China-based chemical supplier and CDMO offering building blocks, intermediates, APIs, and custom synthesis. A direct competitor to BOC Sciences' research chemicals and impurity standards business with cost-competitive positioning.
• Santa Cruz Biotechnology: Supplier of research reagents including antibodies, biochemicals, and small-molecule inhibitors for life science research. Directly comparable to BOC Sciences' small-molecule inhibitors, fluorescent probes, and research chemicals product lines targeting academic and biotech researchers.

Broad incumbents

• Sigma-Aldrich (Merck KGaA / MilliporeSigma): World's largest research chemicals supplier offering hundreds of thousands of catalog products including impurities, intermediates, and reagents. Comparable to BOC Sciences' catalog business at vastly greater scale and broader portfolio including life science tools and biopharma services.
• Catalent: Large global CDMO providing formulation, drug delivery, and commercial manufacturing services across small molecules and biologics. Comparable to BOC Sciences' CDMO and drug delivery platforms (nanoparticles, liposomes) but at significantly greater commercial scale.
• Lonza: Global CDMO leader offering small-molecule APIs, biologics manufacturing, and cell & gene therapy services. Comparable to BOC Sciences' CDMO/API business and mRNA manufacturing platforms, though at vastly larger scale and broader modality coverage.
• Bio-Techne: Public life science tools company offering reagents, proteins, antibodies, and GMP-grade cytokines for research and cell therapy manufacturing. Comparable to BOC Sciences' GMP products and life science reagents portfolio with deeper biologics focus and stronger brand.

Emerging players

• Bachem: Specialized CDMO focused on peptide and oligonucleotide API manufacturing with cGMP capabilities. Comparable to BOC Sciences' custom synthesis and CDMO capabilities for peptide-based and oligonucleotide chemistries, though with deeper specialization in peptide API manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/bocsciences
• Facebookfacebook.com/BOCSciences
• LinkedInlinkedin.com/company/boc-sciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOC Sciences